Sempermed announces its new StarMed ® Ultra Nitrile examination glove. StarMed® Ultra Nitrile is the latest addition to the StarMed ® family (following the StarMed® Latex launch in April 2013). StarMed® Ultra Nitrile is manufactured with a second generation nitrile formula, providing an incomparable fit and feel without sacrificing the protection and peace of mind healthcare workers demand.
This unique formula reduces tackiness thus allowing for a quick and easy don. StarMed® Ultra Nitrile also carries the new Smart Dispense Technology, Single Glove Delivery System seal ensuring each box is packed to perfection and dispenses one glove at a time. This new technology is proven to eliminate unnecessary hassle and waste. Additionally, each box of StarMed® Ultra Nitrile contains 250 gloves (225 XL), providing even greater efficiencies to those in need of hand protection.
Due to the enhanced nitrile characteristics and innovative packaging, we expect StarMed® Ultra Nitrile to be a quick favorite, specifically to those involved in the medical and dental industries, says Brooke Rosenberg, director of marketing. Also by packaging in 250 per box we are helping our customers save money as well as staying in line with our Glove the Planet sustainability campaign."
The superior StarMed® Ultra Nitrile hand protection is available in sizes extra small through extra large. The product reorder numbers are SMTN251 (size x-small), SMTN252 (size small), SMTN253 (size medium), and SMTN254 (size large), and SMTN255 (size x-large).
Source: Sempermed USA, Inc.
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.